From Foodborne Pollutant Carrier to Gastrointestinal Trojan Horse: Simulating the Bioaccessibility of Antibiotics

Shuliang Tan1,2, Ying Zhang1, Lingling Liu1

  • 1Food Safety and Health Research Center, Guangdong Provincial Key Laboratory of Tropical Disease Research, BSL-3 Laboratory (Guangdong), School of Public Health, Southern Medical University, Guangzhou 510640, China.

Foods (Basel, Switzerland)
|February 27, 2026
PubMed

Insights

Aged polylactic acid microplastics (MPs) can carry antibiotics like tetracycline (TC) through the human gut. These MPs release significant amounts of TC during digestion, posing food safety risks.

Area of Science:

  • Environmental Science
  • Food Safety
  • Materials Science

Background:

  • Foodborne microplastics (MPs) are potential vectors for co-ingested contaminants.
  • The digestive fate and transport of antibiotics by MPs remain poorly understood.
  • Polylactic acid (PLA) is a common food-contact material susceptible to environmental aging.

Purpose of the Study:

  • To investigate the role of aged PLA MPs in transporting tetracycline (TC) through the human gastrointestinal tract.
  • To characterize the influence of aging on PLA MPs' adsorption properties for TC.
  • To assess the bioaccessibility of TC released from aged PLA MPs during simulated digestion.

Main Methods:

  • Environmentally aged PLA MPs using K2S2O8.
  • Adsorption kinetics and thermodynamics of TC onto aged PLA MPs.
  • In vitro simulated digestion models (gastric and intestinal phases).

Main Results:

  • Aging significantly increased PLA MPs' porosity, hydrophilicity, and TC adsorption capacity (0.54 to 0.95 mg/g).
  • Adsorption was primarily driven by hydrogen bonding and electrostatic forces.
  • Simulated intestinal fluid enhanced TC release (up to 62.7%), with an overall bioaccessibility of 32.6%.

Conclusions:

  • Aged PLA MPs can act as 'Trojan horses' for foodborne antibiotics like TC during digestion.
  • The study provides a framework for assessing microplastic-vectored contaminant exposure.
  • Findings highlight potential risks to food safety and human health from aged MPs in food.

Related Concept Videos

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
269
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
624
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
269
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
58